Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Esmolol on Tissue Perfusion and Clinical Prognosis of Patients With Severe Sepsis: a Prospective Cohort Study .

NCT02794025 is registered in ClinicalTrials.gov with Fujian Provincial Hospital as lead sponsor.

NCT NCT02794025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02794025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Esmolol on Tissue Perfusion and Clinical Prognosis of Patients With Severe Sepsis: a Prospective Cohort Study .
Lead sponsor
Fujian Provincial Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
January 31, 2013
Enrollment
151 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe sepsis